Related Experiment Videos
[New gestagens--advantages and disadvantages]
1Zentrum der Frauenheilkunde und Geburtshilfe, Klinikum der J.W. Goethe-Universität Frankfurt am Main. H.Kuhl@em.uni-frankfurt.de
Therapeutische Umschau. Revue Therapeutique
|October 12, 2001
Summary
Synthetic progestagens offer high oral bioavailability for therapy, hormone replacement, and contraception. Different progestogen types vary in efficacy and hormonal profiles, allowing tailored treatment choices for women.
Area of Science:
- Pharmacology
- Endocrinology
- Synthetic chemistry
Context:
- Synthetic progestagens are widely used for therapeutic applications including hormone replacement therapy and contraception due to their high oral bioavailability.
- Various classes of progestogens exist, including progesterone derivatives, nortestosterone derivatives (13-methyl-gonanes and 13-ethyl-gonanes), spirolactone derivatives, and norpregnane derivatives.
Purpose:
- To review the different types of synthetic progestagens, their hormonal profiles, and their therapeutic applications.
- To highlight the varying efficacies and hormonal activities of different progestogen classes.
Summary:
- All progestagens exhibit antiestrogenic activity, inhibiting endometrial proliferation and reducing the risk of endometrial hyperplasia.
- Nortestosterone derivatives, except Dienogest, possess a 17-alpha-ethynyl group and may have mild androgenic properties. Some are prodrugs, rapidly converting to active forms post-administration.
- Spirolactone derivatives like Drospirenone have antimineralocorticoid and antiandrogenic effects. Progesterone derivatives and certain others (Gestodene, Desogestrel) show mild glucocorticoid activity.
- 19-norpregnane derivatives' effects are similar to progesterone derivatives.
Impact:
- The diverse hormonal profiles of synthetic progestagens enable individualized selection for optimal contraception and hormone replacement therapy in women.
- Understanding these profiles is crucial for managing potential side effects and optimizing therapeutic outcomes.